NCT06277193

Investigation of the Relationship Between Sarcopenia and Balance, Fear of Falling and Fall Risk in Older Female Patients

Konya Beyhekim Training and Research Hospital·ClinicalTrials.gov·diagnostic testCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Sarcopenia
Drug/Device/Intervention
valuation of balance status, fear of falling and risk of falling in patients non-sarcopenia.
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Konya Beyhekim Training and Research Hospital
Location
Selçuklu, Turkey
Timeline & enrollment
Phase
N/A
Start date
Nov 03, 2020
End date
Sep 28, 2023
Enrollment
166 participants
Primary outcome

Sociodemographic data,Berg Balance Scale(BBS),Falls Efficacy Scale (FES),Balance and Gait Assessment Scale

Summary

This study (study type: cross-sectional) aims to investigate the relationship of sarcopenia
 level with balance, fear of falling and risk of falling in the elderly female population. In
 the first stage, 166 participants were divided into two groups: sarcopenia and
 non-sarcopenia. Afterwards, they were categorized according to sarcopenia level (probable
 sarcopenia group, sarcopenia group, severe sarcopenia group, group without sarcopenia) and
 comparisons were made between these subgroups. Then, they were evaluated with various scales
 and tests (in terms of balance, fear of falling and risk of falling).

ICD-10 classifications
Kaposi sarcomaHerniaTaeniasisTaenia saginata taeniasisDiaphragmatic hernia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06277193
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06277193 through Pure Global AI's free database. This phase not specified trial is sponsored by Konya Beyhekim Training and Research Hospital and is currently Completed. The study focuses on Sarcopenia. Target enrollment is 166 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.